The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy
Therapeutics and Clinical Risk Management, 05/18/2012
Gudin JA – Although currently voluntary, future policy will likely dictate that providers undergo mandatory training to continue prescribing medications within this class. This article outlines the elements of the class–wide Risk Evaluation and Mitigation Strategy (REMS) for ER opioids and clarifies the impact on primary care providers with regard to training, patient education, and clinical practice.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.